— Know what they know.
Not Investment Advice

HLVX NASDAQ

HilleVax, Inc.
1W: +0.0% 1M: +1.5% 3M: +11.2% 1Y: +16.8% 3Y: -90.5%
$2.09
Last traded 2025-09-18 — delisted
NASDAQ · Healthcare · Biotechnology · $104.8M mcap · 23M float · 3.16% daily turnover · Short 47% of daily vol

Cash Flow Trends

Operating Cash Flow
-$109M -25.4% ▼
Capital Expenditures
$522K +95.1% ▲
Free Cash Flow
-$109M -12.1% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$62M +0.8% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$2M-$102M-$160M-$124M-$147M
Depreciation & Amort.$0$3K$1K$2M$3M
Stock-Based Comp.$0$67K$3M$14M$21M
Change in Working Capital$52K$11M-$5M$23M-$15M
Other Non-Cash Items$779K$58M$100M-$2M$29M
Operating Cash Flow-$1M-$7M-$62M-$87M-$109M
— Investing Activities —
Capital Expenditures$0-$3M-$7M-$11M-$522K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0-$144M-$155M
Investment Sales$0$0$0$60M$230M
Other Investing$0-$3K-$2K$0-$15M
Investing Cash Flow$0-$3M-$7M-$95M$58M
— Financing Activities —
Net Debt Issuance$0$135M$15M$10M-$27M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$1M-$789K$0$0$0
Financing Cash Flow$1M$134M$225M$119M-$12M
Net Change in Cash$54K$124M$156M-$63M-$62M
Cash End of Period$457K$125M$281M$218M$156M
Free Cash Flow-$1M-$10M-$69M-$98M-$109M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms